國家衛生研究院 NHRI:Item 3990099045/13046
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 907581      Online Users : 961
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version


    Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/13046


    Title: c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation
    Authors: Chang, TM;Chu, PY;Hung, WC;Shan, YS;Lin, HY;Huang, KW;Chang, JS;Chen, LT;Tsai, HJ
    Contributors: National Institute of Cancer Research
    Abstract: Pancreatic neuroendocrine tumor (pNET) is a pancreatic neoplasm with neuroendocrine differentiation. pNET in early stage can be treated with surgical resection with long-term survival whereas the prognosis of pNET with locoregional or distant metastasis is relatively poor. Lymphangiogenesis is essential for tumor metastasis via lymphatic system and may overhead distant metastasis. c-Myc overexpression is involved in tumorigenesis. The role of c-Myc in lymphangiogenesis is unclear. In this study, we evaluated the mechanism and effect of c-Myc on lymphangiogenesis of pNET via interaction of lymphatic endothelial cells (LECs) and pNET cells. Lymph node metastasis was evaluated in pNET xenograft mice. Potential target agents to inhibit lymph node metastasis were evaluated in animal model. We found that vascular endothelial growth factor C (VEGFC) expression and secretion was increased in pNET cell lines with c-Myc overexpression. c-Myc transcriptionally upregulates VEGFC expression and secretion of pNET cells through direct binding to E-box of VEGFC promoter and enhanced VEGF receptor 3 phosphorylation and tube formation of LECs. c-Myc overexpression is associated with lymph node metastasis in pNET xenograft mice. Combinational treatment of mTOR inhibitor with c-Myc inhibitor or VEGFC neutralizing chimera protein reduced lymph node metastasis of the mice with c-Myc overexpression. mTOR inhibitor acts on lymphangiogenesis via reducing VEGFC expression in pNET cells and inhibiting tube formation of LECs. In conclusion, mTOR and c-Myc are important for lymphangiogenesis of pNET and are potential therapeutic targets for prevention and treatment of lymph node metastasis in pNET.
    Date: 2021-01
    Relation: Cancer Science. 2021 Jan;112(1):243-253.
    Link to: http://dx.doi.org/10.1111/cas.14717
    JIF/Ranking 2023: http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=NHRI&SrcApp=NHRI_IR&KeyISSN=1347-9032&DestApp=IC2JCR
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000591671200001
    Cited Times(Scopus): https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85097006001
    Appears in Collections:[Hui-Jen Tsai] Periodical Articles
    [Li-Tzong Chen] Periodical Articles
    [Jeffrey Shu-Ming] Periodical Articles
    [Wen-Chun Hung] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    PUB33128283.pdf974KbAdobe PDF322View/Open


    All items in NHRI are protected by copyright, with all rights reserved.

    Related Items in TAIR

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback